
Lead. Anyone who has pulled an all-nighter knows that sleep loss can make the whole body ache. But the brain wiring that turns missed sleep into physical pain has remained a black box, until now. A study published July 20 in Cell Reports identifies, for the first time, a specific three-part brain circuit that drives pain hypersensitivity after sleep deprivation. Researchers at Sun Yat-Sen University in Guangzhou and Shenzhen, China, traced the signal from a sensory processing hub in the back of the brain all the way down to a tiny inhibitory structure buried deep in the subthalamus, and showed that manipulating any link in this chain can dial pain up or down.
The discovery gives scientists a concrete neural target for treating the widespread but poorly understood link between poor sleep and chronic pain.
The circuit revealed. The team, led by Ruizhen Huang and Yuting Wang, used a battery of state-of-the-art techniques, including brain-wide neural tracing, optogenetics (controlling neurons with light), chemogenetics (controlling neurons with designer drugs), fiber photometry, and electrophysiology, to map the circuit from end to end.
They identified three nodes connected in sequence. The first is the retrosplenial cortex (RSC), a region involved in spatial navigation and memory. Glutamatergic (excitatory) neurons in the RSC send projections to the anterior cingulate cortex (ACC), a well-known hub for pain processing. In turn, ACC glutamatergic neurons project to the zona incerta (ZI), a small but powerful inhibitory structure beneath the thalamus that has been implicated in pain modulation, sleep-wake regulation, and attention.
This is the first characterization of a specific tripartite circuit encoding pain from sleep loss. Earlier work had linked sleep deprivation to generalized changes in pain-related brain activity, but no study had mapped the full chain of neurons connecting sleeplessness to pain behavior.
The behavioral link. To test whether this circuit actually drives pain, the researchers subjected mice to nine hours of sleep deprivation, a well-established protocol that induces mechanical and thermal pain hypersensitivity in rodents. Sleep-deprived mice showed significantly increased activity in ACC glutamatergic neurons, as measured by fiber photometry. When the team used optogenetics to inhibit those same ACC neurons, the pain hypersensitivity was relieved, the mice became less sensitive to painful stimuli despite having lost sleep.
The RSC turned out to be the upstream driver of this ACC hyperactivity. Activating RSC glutamatergic neurons that project to the ACC was sufficient to induce pain-like behavior in well-rested mice. Conversely, chemogenetically silencing the RSC-to-ACC connection in sleep-deprived mice reversed their pain sensitivity back toward normal levels.
At the other end of the circuit, the team found that ACC glutamatergic neurons densely innervate the zona incerta, and that ZI GABAergic (inhibitory) neurons became hyperactive after sleep deprivation. Inhibiting the ACC-to-ZI connection also attenuated sleep deprivation-induced pain. In a final confirmation, the researchers ablated ACC glutamatergic neurons and found that this completely reversed the pain-promoting effect of RSC-to-ACC circuit activation.
The data make a compelling case that this three-node pathway is both necessary and sufficient for translating acute sleep loss into measurable pain hypersensitivity.
Why it matters. Chronic pain and sleep disorders are among the most common and debilitating health complaints worldwide, and they are often locked in a vicious cycle: pain disrupts sleep, and poor sleep amplifies pain. Clinical studies have estimated that up to 67 percent of people with chronic pain also report poor sleep quality. Yet treatment options that target this intersection are scarce, in part because the underlying neurobiology has been so poorly understood.
By identifying a specific, manipulable circuit from RSC to ACC to ZI, the study provides a roadmap for developing therapies that could break the sleep-pain cycle. Drugs or neuromodulation techniques that quiet ACC glutamatergic activity or enhance ZI GABAergic inhibition might offer relief for patients whose pain is driven or worsened by insufficient sleep.
The findings also highlight the ACC as a particularly compelling target. This cortical region has been studied extensively in the context of pain perception, emotional processing, and decision-making. The new results place it squarely at the center of sleep-pain interactions and suggest that therapies already in development for pain, such as ACC-targeted deep brain stimulation or transcranial magnetic stimulation, could be repurposed for sleep-related pain conditions.
Limits. The study was conducted in mice, and rodent sleep deprivation protocols do not perfectly replicate the complex, chronic sleep loss patterns seen in human patients. Nine hours of acute sleep deprivation is a relatively short perturbation; whether the same circuit mediates pain hypersensitivity after weeks or months of poor sleep remains unknown. The work focused on a single circuit, but other pathways likely contribute as well. Finally, optogenetic and chemogenetic tools are not yet available for clinical use, so translating these findings into human therapies will require drug development or noninvasive neuromodulation approaches that can selectively target ACC or ZI activity.
Bottom line. Sleep loss amplifies pain through a specific three-neuron circuit running from the retrosplenial cortex to the anterior cingulate cortex to the zona incerta. Activating ACC glutamatergic neurons is the central mechanism, and silencing any link in the chain relieves pain hypersensitivity in sleep-deprived mice. The circuit provides a concrete neural target for treating the sleep-pain connection that affects millions of people worldwide.
Source. Huang R, Wang Y, et al. “A cortical-subcortical circuit underlies pain sensitization driven by sleep deprivation.” Cell Reports, July 20, 2026. DOI: 10.1016/j.celrep.2026.117693. Sun Yat-Sen University, Guangzhou and Shenzhen, China. Published July 20, 2026.

